阿基纳1缺乏症:一种可治疗的性的形式
Alessandro Burlina1, Anna Ardissone2, Roberta Battini3,4
1Dept. of Medicine, Neurology Unit, St. Bassiano Hospital, Via dei Lotti 40, 36061, Bassano del Grappa, Italy. alessandro.burlina@aulss7.veneto.it.
概括
阿基因酶1缺乏症 (ARG1-D) 是一种罕见的神经系统疾病,经常被误诊. 早期识别诸如性和认知障碍等症状,然后及时进行治疗,对于改善患者的治疗结果至关重要.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学是一种遗传学.
- 神经学 神经学
背景情况:
- 阿基因酶1缺乏症 (ARG1-D) 是一种罕见的尿素循环障碍,由于阿基因因水平升高,导致神经功能受损.
- 由于症状重叠和新生儿查有限,晚期诊断很常见,阻碍了早期干预.
研究的目的:
- 审查ARG1-D的临床表现,诊断挑战和治疗方法.
- 为专家提供一个实用的资源,以识别这种渐进的,可治疗的疾病.
主要方法:
- 文献综述和专家意见综合.
- 对临床表现,诊断标准和治疗策略的分析.
主要成果:
- ARG1-D呈现出性,发育迟缓,认知障碍和发作.
- 不同诊断包括遗传性性和脑.
- 诊断依赖于生物化学试验 (高血) 和遗传检测.
- 治疗包括改变饮食,吸剂和新疗法,如子氨酶.
结论:
- 提高对ARG1-D特征的认识对于早期识别和改善患者结果至关重要.
- 识别独特的特征和诊断工具可以防止在非专业环境中误诊.
更多相关视频
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
20.5K
09:23Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections
Published on: March 26, 2016
13.1K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
980
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
980
01:15Myasthenia Gravis: Diagnostic Tests
554
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
554